Open AccessVP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication
Author(s) -
Jun Yi
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i41.6429
Subject(s) - hepatitis b virus , mutant , hbsag , microbiology and biotechnology , transfection , viral replication , biology , virology , plasmid , fusion protein , mtt assay , cell culture , virus , dna , gene , biochemistry , recombinant dna , genetics
To investigate the inhibitory effect of VP22 fusion protein-based dominant negative (DN) mutant on Hepatitis Bvrus (HBV) replication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom